moomoo ID:0
Log Out
  • English
  • 中文繁体
  • 中文简体

$3 Million Bet On This Communication Services Stock? Check Out These 4 Penny Stocks Insiders Are Buying

Benzinga Real-time News ·  08/22 23:10

The Dow Jones dropped more than 290 points on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

Nextdoor Holdings

  • The Trade: Nextdoor Holdings, Inc. (NYSE:KIND) Director David Sze bought a total of 900,000 shares at an average price of $3.35. To acquire these shares, it cost around $3.02 million.
  • What's Happening: Nextdoor Holdings recently reported worse-than-expected Q2 results and issued weak guidance.
  • What Nextdoor Holdings Does: Nextdoor Holdings Inc is the platform to connect to the neighborhoods.


  • The Trade: BARK, Inc. (NYSE:BARK) Director David Kamenetzky acquired a total of 91,832 shares at an average price of $2.47. The insider spent around $226.56 thousand to buy those shares.
  • What's Happening: Bark filed prospectus related to issuance by company of up to 4.6 million shares of common stock.
  • What BARK Does: BARK Inc is a dog-centric company, devoted to making dogs happy with the products, services, and content.

Nasdaq Futures Down 200 Points Following Friday's Plunge; Crude Oil Drops

Don't forget to check out our premarket coverage here .

Cumberland Pharmaceuticals

  • The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Director Joseph C Galante acquired a total of 2,125 shares at an average price of $2.31. To acquire these shares, it cost around $4.91 thousand.
  • What's Happening: Cumberland recently posted a Q2 loss of $0.01 per share.
  • What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products.


  • The Trade: OppFi Inc. (NYSE:OPFI) CEO Todd G Schwartz acquired a total of 15,930 shares at an average price of $2.57. The insider spent $41.01 thousand to buy those shares.
  • What's Happening: The company recently posted upbeat quarterly results.
  • What OppFi Does: OppFi Inc is a financial technology platform that powers banks to help the everyday consumer gain access to credit.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites and Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.